270 related articles for article (PubMed ID: 34013359)
1. Anti-Müllerian hormone concentration regulates activin receptor-like kinase-2/3 expression levels with opposing effects on ovarian cancer cell survival.
Chauvin M; Garambois V; Choblet S; Colombo PE; Chentouf M; Gros L; De Brauwere DP; Duonor-Cerutti M; Dumas K; Robert B; Jarlier M; Martineau P; Navarro-Teulon I; Pépin D; Chardès T; Pèlegrin A
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34013359
[TBL] [Abstract][Full Text] [Related]
2. Anti-Müllerian hormone (AMH) autocrine signaling promotes survival and proliferation of ovarian cancer cells.
Chauvin M; Garambois V; Colombo PE; Chentouf M; Gros L; Brouillet JP; Robert B; Jarlier M; Dumas K; Martineau P; Navarro-Teulon I; Pépin D; Chardès T; Pèlegrin A
Sci Rep; 2021 Jan; 11(1):2231. PubMed ID: 33500516
[TBL] [Abstract][Full Text] [Related]
3. Anti-Müllerian hormone inhibits growth of AMH type II receptor-positive human ovarian granulosa cell tumor cells by activating apoptosis.
Anttonen M; Färkkilä A; Tauriala H; Kauppinen M; Maclaughlin DT; Unkila-Kallio L; Bützow R; Heikinheimo M
Lab Invest; 2011 Nov; 91(11):1605-14. PubMed ID: 21808236
[TBL] [Abstract][Full Text] [Related]
4. Mullerian inhibiting substance recruits ALK3 to regulate Leydig cell differentiation.
Wu X; Zhang N; Lee MM
Endocrinology; 2012 Oct; 153(10):4929-37. PubMed ID: 22872577
[TBL] [Abstract][Full Text] [Related]
5. The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor protein and mRNA in benign, borderline and malignant ovarian neoplasia.
Song JY; Chen KY; Kim SY; Kim MR; Ryu KS; Cha JH; Kang CS; MacLaughlin DT; Kim JH
Int J Oncol; 2009 Jun; 34(6):1583-91. PubMed ID: 19424576
[TBL] [Abstract][Full Text] [Related]
6. Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian Cancer.
Basal E; Ayeni T; Zhang Q; Langstraat C; Donahoe PK; Pepin D; Yin X; Leof E; Cliby W
Curr Mol Med; 2016; 16(3):222-31. PubMed ID: 26917267
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Anti-Mullerian Hormone and Anti-Mullerian Hormone Type II Receptor Variants in Women with Repeated Implantation Failures.
Fu YX; Yang HM; OuYang XE; Hu R; Hu T; Wang FM
Reprod Sci; 2021 Feb; 28(2):406-415. PubMed ID: 32845508
[TBL] [Abstract][Full Text] [Related]
8. Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications.
Donahoe PK; Clarke T; Teixeira J; Maheswaran S; MacLaughlin DT
Mol Cell Endocrinol; 2003 Dec; 211(1-2):37-42. PubMed ID: 14656474
[TBL] [Abstract][Full Text] [Related]
9. Expression of Müllerian-Inhibiting Substance/Anti-Müllerian Hormone Type II Receptor in the Human Theca Cells.
Cheon KY; Chung YJ; Cho HH; Kim MR; Cha JH; Kang CS; Lee JY; Kim JH
J Clin Endocrinol Metab; 2018 Sep; 103(9):3376-3385. PubMed ID: 29947765
[TBL] [Abstract][Full Text] [Related]
10. Activin receptor-like kinase-2 inhibits activin signaling by blocking the binding of activin to its type II receptor.
Renlund N; O'Neill FH; Zhang L; Sidis Y; Teixeira J
J Endocrinol; 2007 Oct; 195(1):95-103. PubMed ID: 17911401
[TBL] [Abstract][Full Text] [Related]
11. Anti-Müllerian hormone recruits BMPR-IA in immature granulosa cells.
Sèdes L; Leclerc A; Moindjie H; Cate RL; Picard JY; di Clemente N; Jamin SP
PLoS One; 2013; 8(11):e81551. PubMed ID: 24312319
[TBL] [Abstract][Full Text] [Related]
12. Anti-Mullerian-hormone-dependent regulation of the brain serine-protease inhibitor neuroserpin.
Lebeurrier N; Launay S; Macrez R; Maubert E; Legros H; Leclerc A; Jamin SP; Picard JY; Marret S; Laudenbach V; Berger P; Sonderegger P; Ali C; di Clemente N; Vivien D
J Cell Sci; 2008 Oct; 121(Pt 20):3357-65. PubMed ID: 18796535
[TBL] [Abstract][Full Text] [Related]
13. Natural mutations of the anti-Mullerian hormone type II receptor found in persistent Mullerian duct syndrome affect ligand binding, signal transduction and cellular transport.
Belville C; Maréchal JD; Pennetier S; Carmillo P; Masgrau L; Messika-Zeitoun L; Galey J; Machado G; Treton D; Gonzalès J; Picard JY; Josso N; Cate RL; di Clemente N
Hum Mol Genet; 2009 Aug; 18(16):3002-13. PubMed ID: 19457927
[TBL] [Abstract][Full Text] [Related]
14. Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regression.
Zhan Y; Fujino A; MacLaughlin DT; Manganaro TF; Szotek PP; Arango NA; Teixeira J; Donahoe PK
Development; 2006 Jun; 133(12):2359-69. PubMed ID: 16687449
[TBL] [Abstract][Full Text] [Related]
15. Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth.
Baarends WM; Uilenbroek JT; Kramer P; Hoogerbrugge JW; van Leeuwen EC; Themmen AP; Grootegoed JA
Endocrinology; 1995 Nov; 136(11):4951-62. PubMed ID: 7588229
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein 2 regulates cell-cell communication by down-regulating connexin43 expression in luteinized human granulosa cells.
Wu YT; Chang HM; Huang HF; Sheng JZ; Leung PC
Mol Hum Reprod; 2017 Mar; 23(3):155-165. PubMed ID: 27986931
[TBL] [Abstract][Full Text] [Related]
17. Functional redundancy of TGF-beta family type I receptors and receptor-Smads in mediating anti-Mullerian hormone-induced Mullerian duct regression in the mouse.
Orvis GD; Jamin SP; Kwan KM; Mishina Y; Kaartinen VM; Huang S; Roberts AB; Umans L; Huylebroeck D; Zwijsen A; Wang D; Martin JF; Behringer RR
Biol Reprod; 2008 Jun; 78(6):994-1001. PubMed ID: 18322278
[TBL] [Abstract][Full Text] [Related]
18. Anti-Müllerian Hormone Signaling Regulates Epithelial Plasticity and Chemoresistance in Lung Cancer.
Beck TN; Korobeynikov VA; Kudinov AE; Georgopoulos R; Solanki NR; Andrews-Hoke M; Kistner TM; Pépin D; Donahoe PK; Nicolas E; Einarson MB; Zhou Y; Boumber Y; Proia DA; Serebriiskii IG; Golemis EA
Cell Rep; 2016 Jul; 16(3):657-71. PubMed ID: 27396341
[TBL] [Abstract][Full Text] [Related]
19. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
[TBL] [Abstract][Full Text] [Related]
20. Anti-Müllerian Hormone Type II Receptor Expression in Endometrial Cancer Tissue.
Gowkielewicz M; Lipka A; Majewska M; Piotrowska A; Szadurska-Noga M; Nowakowski JJ; Wiszpolska M; Dzięgiel P; Wasniewski T; Majewski MK; Jozwik M
Cells; 2020 Oct; 9(10):. PubMed ID: 33080800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
